Compound 2214
Identifiers
- Canonical SMILES:
CCn1c2NC3=C(C(c4ccc(C)cc4)c2c(=O)n(C)c1=O)C(=O)OC3
- IUPAC name:
13-ethyl-11-methyl-8-(4-methylphenyl)-5-oxa-2,11,13-triazatricyclo[7.4.0.0^{3,7}]trideca-1(9),3(7)-diene-6,10,12-trione
- InChi:
InChI=1S/C19H19N3O4/c1-4-22-16-15(17(23)21(3)19(22)25)13(11-7-5-10(2)6-8-11)14-12(20-16)9-26-18(14)24/h5-8,13,20H,4,9H2,1-3H3
- InChiKey:
UVXLCDRWDGHQDE-UHFFFAOYSA-N
External links
![]() 137643820 |
![]() CHEMBL4085767 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 353.14 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 1.55 | |||
TPSA | 78.95 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.3907 | Lercanidipine | DB00528 | |
0.3849 | 5-(6-D-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-pentyl-phosphonic acid | DB04266 | |
0.3791 | Manidipine | DB09238 | |
0.3785 | Benidipine | DB09231 | |
0.3741 | Alogliptin | DB06203 | |
0.3740 | Mavacamten | DB14921 | |
0.3737 | Barnidipine | DB09227 | |
0.3732 | Niguldipine | DB09239 | |
0.3732 | Dexniguldipine | DB14068 | |
0.3719 | LY249543 | DB04322 | |
0.3719 | Lometrexol | DB12769 | |
0.3677 | Azelnidipine | DB09230 | |
0.3672 | Cronidipine | DB09233 | |
0.3656 | Nicardipine | DB00622 | |
0.3620 | Trelagliptin | DB15323 |